Team:SupBiotech-Paris/Bibliographie

From 2009.igem.org

(Difference between revisions)
Line 48: Line 48:
|height=40px|Vectorisation
|height=40px|Vectorisation
|[1]
|[1]
-
|
+
|Couvreur P.
-
|
+
|L'encapsulation de médicament
-
|
+
|2003
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[2]
|[2]
-
|
+
|Andrieux K. and al.
-
|
+
|Nanotechnology and new drug
-
|
+
|2003
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[3]
|[3]
-
|
+
|Torchilin V.P.
-
|
+
|Recent Approaches to Intracellular Delivery of Drugs and DNA and Organelle Targeting
-
|
+
|2006
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[4]
|[4]
-
|
+
|Davis M.E. and al.
-
|
+
|Nanoparticle therapeutics: an emerging treatment modality for cancer
-
|
+
|2008
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[5]
|[5]
-
|
+
|Seow Y. and al.
-
|
+
|Biological Gene Delivery Vehicles: Beyond Viral Vectors
-
|
+
|2009
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[6]
|[6]
-
|
+
|Decroly E.
-
|
+
|Vectorology
-
|
+
|2005
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[7]
|[7]
-
|
+
|Robbins P.D. and al.
-
|
+
|Viral Vectors for Gene Therapy
-
|
+
|1998
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[8]
|[8]
-
|
+
|Wei M.Q. and al.
-
|
+
|Bacterial targeted tumour therapy-dawn of a new era
-
|
+
|2008
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[9]
|[9]
-
|
+
|Ryan R.M. and al.
-
|
+
|Use of bacteria in anti-cancer therapies
-
|
+
|2005
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[10]
|[10]
-
|
+
|Mehnert
-
|
+
|Solid lipid nanoparticles: Production, characterization and applications
-
|
+
|2001
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[11]
|[11]
-
|
+
|Lasic D.D.
-
|
+
|Liposomes in gene therapy
-
|
+
|1996
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[12]
|[12]
-
|
+
|Lutten J. and al.
-
|
+
|Biodegradable polymers as non-viral carriers for plasmid DNA delivery
-
|
+
|2008
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[13]
|[13]
-
|
+
|Jiskoot W. and al.
-
|
+
|Immunological Risk of Injectable Drug Delivery Systems
-
|
+
|2009
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[14]
|[14]
-
|
+
|Head M. and al.
-
|
+
|Mechanism and computer simulation of immune complex formation, opsonization, and clearance
-
|
+
|1996
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Vectorisation
|height=40px|Vectorisation
|[15]
|[15]
-
|
+
|Koide H. and al.
-
|
+
|Particle size-dependent triggering of accelerated blood clearance phenomenon
-
|
+
|2008
 +
 
 +
|- style="background: white; text-align: center;"
 +
|height=40px|Vectorisation
 +
|[16]
 +
|Ishida T. and al.
 +
|Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes
 +
|2005
 +
 
 +
|- style="background: #C0C0C0; text-align: center;"
 +
|height=40px|Vectorisation
 +
|[17]
 +
|Wang XY and al.
 +
|Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes
 +
|2007
 +
 
 +
|- style="background: white; text-align: center;"
 +
|height=40px|Vectorisation
 +
|[18]
 +
|Tosi M.F. and al.
 +
|Innate immune responses to infection
 +
|2005
 +
 
 +
|- style="background: #C0C0C0; text-align: center;"
 +
|height=40px|Vectorisation
 +
|[19]
 +
|Linkov I and al.
 +
|Nanotoxicology and nanomedicine: making hard decisions
 +
|2008
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"

Revision as of 17:41, 20 October 2009

framless


Chapitre Ref. Auteurs Titre Année
Thérapie actuelle [1] Lechat P. Pharmacology 2006
Thérapie actuelle [2] Bruguerolle B. Biological rhythms and medications: a source of variability often neglected in pharmacology 2008
Thérapie genique [1] Kevin J. Scanlon and al. Cancer Gene Therapy: Challenges and Opportunities 2004
Thérapie genique [2] Gouze JN and al. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer 2003
Thérapie génique [3] Centre for Genetics Education http://www.genetics.com.au/index.asp XXXX
Vectorisation [1] Couvreur P. L'encapsulation de médicament 2003
Vectorisation [2] Andrieux K. and al. Nanotechnology and new drug 2003
Vectorisation [3] Torchilin V.P. Recent Approaches to Intracellular Delivery of Drugs and DNA and Organelle Targeting 2006
Vectorisation [4] Davis M.E. and al. Nanoparticle therapeutics: an emerging treatment modality for cancer 2008
Vectorisation [5] Seow Y. and al. Biological Gene Delivery Vehicles: Beyond Viral Vectors 2009
Vectorisation [6] Decroly E. Vectorology 2005
Vectorisation [7] Robbins P.D. and al. Viral Vectors for Gene Therapy 1998
Vectorisation [8] Wei M.Q. and al. Bacterial targeted tumour therapy-dawn of a new era 2008
Vectorisation [9] Ryan R.M. and al. Use of bacteria in anti-cancer therapies 2005
Vectorisation [10] Mehnert Solid lipid nanoparticles: Production, characterization and applications 2001
Vectorisation [11] Lasic D.D. Liposomes in gene therapy 1996
Vectorisation [12] Lutten J. and al. Biodegradable polymers as non-viral carriers for plasmid DNA delivery 2008
Vectorisation [13] Jiskoot W. and al. Immunological Risk of Injectable Drug Delivery Systems 2009
Vectorisation [14] Head M. and al. Mechanism and computer simulation of immune complex formation, opsonization, and clearance 1996
Vectorisation [15] Koide H. and al. Particle size-dependent triggering of accelerated blood clearance phenomenon 2008
Vectorisation [16] Ishida T. and al. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes 2005
Vectorisation [17] Wang XY and al. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes 2007
Vectorisation [18] Tosi M.F. and al. Innate immune responses to infection 2005
Vectorisation [19] Linkov I and al. Nanotoxicology and nanomedicine: making hard decisions 2008
Vecteur Tissulaire [1] Ronald S. and al. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies 2009
Vecteur Tissulaire [2] Clark B. Inderlied and al. The Mycobacterium avium Complex 1993
Vecteur Tissulaire [3] Nisheeth Agarwal and al. Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase 2009
Vecteur Tissulaire [4] Hunter R.L. and al. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs 2007
Vecteur Tissulaire [5] Axelrod S and al. Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide 2008
Vecteur Tissulaire [6] Nicole N van der Wel and al. Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy 2005
Vecteur Tissulaire [7] Claudia Nobrega and al. The thymus as a target for mycobacterial infections 2007
Vecteur Cellulaire [1] Harrison Echols and al. Genetic Map of Bacteriophage Lambda 1978
Vecteur Cellulaire [2] Joseph Sambrook and al. Molecular Cloning: A Laboratory Manual (Third Edition) 2001
Vecteur Cellulaire [3] Court DL and al. A New Look at Bacteriophage lambda Genetic Networks 2007
Vecteur Cellulaire [4] Ortega ME and al. Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor 2006
Vecteur Cellulaire [5] Feiss M. and al. Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging 2005
Vecteur Cellulaire [6] Hang JQ and al. The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB 2001
Vecteur Cellulaire [7] Becker A and al. Bacteriophage lambda DNA : The begginning of the End 1990
Vecteur Cellulaire [8] Hochschild A and al. The bactériophage lambda cI protein finds an asymmetric solution 2009
Vecteur Cellulaire [9] Phoebe L.Stewart1 and al. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization 1997
Plasmide thérapeutique [1] Ortega ME et al. Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor 2006
Plasmide thérapeutique [2] Joseph Sambrook and al. Molecular Cloning: A Laboratory Manual (Third Edition) 2001
Plasmide thérapeutique [3] Court DL and al. A New Look at Bacteriophage lambda Genetic Networks 2007
Plasmide thérapeutique [4] Feiss M. and al. Viral Genome Packaging Machines: Genetics, Structure and Mechanism 2005
Plasmide thérapeutique [5] Hang JQ and al. The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB 2001
Plasmide thérapeutique [6] Becker A and al. Bacteriophage lambda DNA : The begginning of the End 1990
Plasmide thérapeutique [7] Young et al. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature 2003
[]


Haut de page


Retrieved from "http://2009.igem.org/Team:SupBiotech-Paris/Bibliographie"